Pharmaceutical Manufacturing of Benzoin Tincture

The contract pertains to the manufacture of Benzoin Tincture, Compound, USP in 60 mL bottles, with strict adherence to United States Pharmacopeia standards and specialized military packaging requirements. The product must meet all applicable USP specifications for composition, potency, and purity, while the packaging must comply with Defense Logistics Agency protocols to ensure durability, labeling accuracy, and readiness for military use. Production is intended to support defense medical supply chains, emphasizing regulatory compliance and quality control throughout the manufacturing process. This subcontract was posted on May 11, 2026, with responses due by May 18, 2026, under NAICS code 325412 for pharmaceutical and medicinal product manufacturing. The procurement is managed by the Department of Defense through the Defense Logistics Agency, and the place of performance, though unspecified, is expected to align with federal contracting guidelines for secure and auditable production sites. All bidders must be prepared to demonstrate capability in pharmaceutical formulation, packaging automation, and compliance with military-grade documentation and traceability standards.